Literature DB >> 15202734

Mean ovarian diameter (MOD) as a predictor of poor ovarian response.

Iavor K Vladimirov1, Desislava M Tacheva, Krassimir B Kalinov.   

Abstract

PURPOSE: To determine the predictive value of mean ovarian diameter of ovarian response in controlled ovarian hyperstimulation (COH), in outcome with normal FSH level in early follicular phase of menstrual cycle.
METHODS: A prospective study established the prognostic value of the mean ovarian diameter of total 57 cases, including 17 patients undergoing IVF treatment with poor ovarian response and 40 patients (control group) with adequate ovarian response.
RESULTS: The mean ovarian diameter (MOD) of patients in the cancelled group was significantly lower (19.23 +/- 2.78) than in a comparable control group (24.67 +/- 3.38) [p < 0.001]. The mean ovarian diameter was a good predictor of poor ovarian response-area under receiver operating characteristic curve-ROCAUC = 0.88. The best criterion value discriminating between cancelled cycle and punctured was < or = 20.6 mm.
CONCLUSIONS: Our data demonstrate that the mean ovarian diameter provides good prognostic information in outcomes with poor ovarian response during controlled ovarian hyperstimulation in IVF. The test is easy to perform and it is a good informative resource.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15202734      PMCID: PMC3455408          DOI: 10.1023/b:jarg.0000027017.32027.df

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  24 in total

Review 1.  A rational approach to the management of low responders in in-vitro fertilization.

Authors:  V Karande; N Gleicher
Journal:  Hum Reprod       Date:  1999-07       Impact factor: 6.918

2.  Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age.

Authors:  J P Toner; C B Philput; G S Jones; S J Muasher
Journal:  Fertil Steril       Date:  1991-04       Impact factor: 7.329

3.  An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog.

Authors:  P Serafini; B Stone; J Kerin; J Batzofin; P Quinn; R P Marrs
Journal:  Fertil Steril       Date:  1988-01       Impact factor: 7.329

4.  The meaning and use of the area under a receiver operating characteristic (ROC) curve.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1982-04       Impact factor: 11.105

5.  Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles.

Authors:  J L Frattarelli; D F Lauria-Costab; B T Miller; P A Bergh; R T Scott
Journal:  Fertil Steril       Date:  2000-09       Impact factor: 7.329

6.  Prognostic assessment of female fecundity.

Authors:  D Navot; Z Rosenwaks; E J Margalioth
Journal:  Lancet       Date:  1987-09-19       Impact factor: 79.321

7.  A comparison between ultrasound and gynecologic examination for detection of enlarged ovaries in a group of women at risk for ovarian carcinoma.

Authors:  S Granberg; M Wikland
Journal:  J Ultrasound Med       Date:  1988-02       Impact factor: 2.153

8.  The gonadotropin-releasing hormone agonist stimulation test--a sensitive predictor of performance in the flare-up in vitro fertilization cycle.

Authors:  K L Winslow; J P Toner; R G Brzyski; S C Oehninger; A A Acosta; S J Muasher
Journal:  Fertil Steril       Date:  1991-10       Impact factor: 7.329

9.  Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting 'poor responders' in in-vitro fertilization.

Authors:  R Fanchin; D de Ziegler; F Olivennes; J Taieb; A Dzik; R Frydman
Journal:  Hum Reprod       Date:  1994-09       Impact factor: 6.918

10.  Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase II, 1981.

Authors:  J E Garcia; G S Jones; A A Acosta; G Wright
Journal:  Fertil Steril       Date:  1983-02       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.